Jennifer Day, MBA, is an experienced oncology professional currently serving as the Lead Regional Oncogenomic Liaison at Exact Sciences since July 2025, focusing on the Oncotype DX Breast Cancer Recurrence Test. Prior to this role, Jennifer held the position of Senior Oncology Specialist at Eisai US, where efforts were directed towards promoting Lenvima for the treatment of hepatocellular carcinoma and advanced renal cell carcinoma. Jennifer's career includes significant contributions at Guardant Health as an Account Executive, specializing in molecular testing, and as a Regional Manager at Invitae, promoting a diverse range of diagnostic testing. Earlier experiences include roles at Roche, Progenity, and Warner Chilcott, demonstrating a strong track record in pharmaceutical sales and business development. Jennifer holds an MBA from Western New England University and a Bachelor's Degree in International Business from Quinnipiac University, alongside educational experiences at the University of London and Beijing Institute of Business.
This person is not in the org chart
This person is not in any teams
This person is not in any offices